|
Real-time Estimate
Cboe BZX
16:39:25 19/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 31.81 USD | +0.03% |
|
+4.37% | +40.61% |
| 08-10 | Damora Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-05 | Damora Therapeutics Begins Trial of DMR-001 in ET, Myelofibrosis | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
DMRA 32.36 $
+1.75%
4.48M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| DMRA | 32.36USD | +1.75% | 4.48M $ | |
CBOE
| DMRA | 32.19USD | +1.00% | 138K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 32.99 | 32.99 | 34.14 |
| Spread/Res. | -1.92% | -1.92% | -5.23% |
| Spread/Supp. | +17.53% | +24.97% | +155.57% |
| Support | 27.53 | 25.89 | 12.66 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DMRA Stock
- Charts Damora Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
